Perioperative outcomes of sinusoidal obstruction syndrome in patients undergoing liver resection for colorectal metastases after neoadjuvant chemotherapy: a retrospective cohort research.
Yoonkyung Woo, Ho Joong Choi, Sung Hak Lee, Yoonyoung Choi, Sung Eun Park, Tae Ho Hong, Young Kyoung You
{"title":"Perioperative outcomes of sinusoidal obstruction syndrome in patients undergoing liver resection for colorectal metastases after neoadjuvant chemotherapy: a retrospective cohort research.","authors":"Yoonkyung Woo, Ho Joong Choi, Sung Hak Lee, Yoonyoung Choi, Sung Eun Park, Tae Ho Hong, Young Kyoung You","doi":"10.4174/astr.2024.107.6.346","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>We investigated the factors that affect the occurrence of sinusoidal obstruction syndrome (SOS) and the effect of SOS on the patient's perioperative outcomes through histological review of liver resection specimens from patients who underwent chemotherapy.</p><p><strong>Methods: </strong>From December 2007 to December 2020, liver specimens from patients who underwent liver resection for colorectal liver metastasis after neoadjuvant chemotherapy were analyzed regarding liver damage in the nontumorous lesion. Through pathological review, patients with grade 1-3 sinusoidal dilatation were categorized into the SOS (+) group, compared to a control group (grade 0, SOS [-]).</p><p><strong>Results: </strong>Of 286 patients, 175 were included. Preoperative factors were similar between the groups. Although not statistically significant, the SOS (+) group had a shorter chemotherapy-free interval before resection (7.96 weeks <i>vs.</i> 10.0 weeks, P = 0.069). The SOS (+) group had higher intraoperative blood loss (889.1 ± 1,126.6 mL <i>vs.</i> 555.3 ± 566.7 mL, P = 0.012) and transfusion rates (46.6% <i>vs.</i> 25.3%, P = 0.003). SOS correlated with increased liver surgery-specific complications (40.9% <i>vs.</i> 26.4, P = 0.043). Patients with SOS experienced adverse effects on intrahepatic recurrent-free survival and overall survival (5-year survival, 46.0% <i>vs.</i> 33.9%; P = 0.014).</p><p><strong>Conclusion: </strong>SOS development during liver surgery is associated with increased intraoperative blood loss, transfusion volume, and liver surgery-specific complications and has a higher risk of early recurrence and decreased overall survival. Thus, it is crucial to exercise caution during liver surgery in these patients.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"107 6","pages":"346-353"},"PeriodicalIF":1.2000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11634394/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Surgical Treatment and Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4174/astr.2024.107.6.346","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/2 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: We investigated the factors that affect the occurrence of sinusoidal obstruction syndrome (SOS) and the effect of SOS on the patient's perioperative outcomes through histological review of liver resection specimens from patients who underwent chemotherapy.
Methods: From December 2007 to December 2020, liver specimens from patients who underwent liver resection for colorectal liver metastasis after neoadjuvant chemotherapy were analyzed regarding liver damage in the nontumorous lesion. Through pathological review, patients with grade 1-3 sinusoidal dilatation were categorized into the SOS (+) group, compared to a control group (grade 0, SOS [-]).
Results: Of 286 patients, 175 were included. Preoperative factors were similar between the groups. Although not statistically significant, the SOS (+) group had a shorter chemotherapy-free interval before resection (7.96 weeks vs. 10.0 weeks, P = 0.069). The SOS (+) group had higher intraoperative blood loss (889.1 ± 1,126.6 mL vs. 555.3 ± 566.7 mL, P = 0.012) and transfusion rates (46.6% vs. 25.3%, P = 0.003). SOS correlated with increased liver surgery-specific complications (40.9% vs. 26.4, P = 0.043). Patients with SOS experienced adverse effects on intrahepatic recurrent-free survival and overall survival (5-year survival, 46.0% vs. 33.9%; P = 0.014).
Conclusion: SOS development during liver surgery is associated with increased intraoperative blood loss, transfusion volume, and liver surgery-specific complications and has a higher risk of early recurrence and decreased overall survival. Thus, it is crucial to exercise caution during liver surgery in these patients.
目的:通过对化疗患者肝切除标本的组织学复习,探讨影响窦状窦梗阻综合征(sinusoidal梗阻综合征,SOS)发生的因素及SOS对患者围手术期预后的影响。方法:分析2007年12月至2020年12月新辅助化疗后行结肝转移肝切除术患者的肝脏标本,分析非肿瘤病变的肝损害情况。通过病理检查,将1-3级窦状窦扩张患者分为SOS(+)组,对照组(0级,SOS[-])。结果:286例患者中,纳入175例。两组术前因素相似。虽然没有统计学意义,但SOS(+)组在切除前无化疗间隔时间较短(7.96周比10.0周,P = 0.069)。SOS(+)组术中出血量(889.1±1126.6 mL比555.3±566.7 mL, P = 0.012)和输血率(46.6%比25.3%,P = 0.003)较高。SOS与肝脏手术特异性并发症增加相关(40.9% vs. 26.4%, P = 0.043)。SOS患者对肝内无复发生存和总生存均有不良影响(5年生存率,46.0% vs. 33.9%;P = 0.014)。结论:肝脏手术中SOS的发生与术中出血量、输血量和肝脏手术特异性并发症的增加有关,具有较高的早期复发风险和降低的总生存期。因此,在这些患者的肝脏手术中谨慎操作是至关重要的。
期刊介绍:
Manuscripts to the Annals of Surgical Treatment and Research (Ann Surg Treat Res) should be written in English according to the instructions for authors. If the details are not described below, the style should follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publications available at International Committee of Medical Journal Editors (ICMJE) website (http://www.icmje.org).